Expertise in
14
conditions

Dr. Colette J. Shen

Radiation Oncology
Office
101 Manning Dr # 7512, 
Chapel Hill, NC 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Expertise in
14
conditions
Office
101 Manning Dr # 7512, 
Chapel Hill, NC 

Overview

Colette Shen is a Radiation Oncologist practicing medicine in Chapel Hill, North Carolina.

Dr. Shen is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Oral Squamous Cell Carcinoma, Throat Cancer, Laryngeal Cancer, and Posterior Fossa Tumor.

She is actively involved in clinical research, co-authoring 71 peer reviewed articles and participating in 7 clinical trials. Dr. Shen is currently accepting new patients.

Specialties

Radiation Oncology

Licenses

Radiology in NC

Hospital Affiliations

Unc Hospitals
Firsthealth Moore Regional Hospital

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Office
101 Manning Dr # 7512, Chapel Hill, NC 27514

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
Enrollment Status: Recruiting
Publish Date: June 25, 2026
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 3
Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a (and Selected T4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
Phase II Randomized Trial of Neoadjuvant Chemotherapy Followed by Surgery and Post-Operative Radiation Versus Surgery and Post-Operative Radiation for Organ Preservation of T3 and T4a (and Selected T4b) Nasal and Paranasal Sinus Squamous Cell Carcinoma (NPNSCC)
Enrollment Status: Active_not_recruiting
Publish Date: August 19, 2026
Intervention Type: Radiation, Drug, Other, Procedure
Study Drugs: Carboplatin, Cisplatin, Docetaxel
Study Phase: Phase 2
Phase I/II Study of Stereotactic Radiosurgery With Concurrent Administration of DNA Damage Response (DDR) Inhibitor (OLAparib) Followed by Adjuvant Combination of DuRvalumab (MEDI4736) and Physician's Choice Systemic Therapy in Subjects With BreAst Cancer Brain Metastases
Phase I/II Study of Stereotactic Radiosurgery With Concurrent Administration of DNA Damage Response (DDR) Inhibitor (OLAparib) Followed by Adjuvant Combination of DuRvalumab (MEDI4736) and Physician's Choice Systemic Therapy in Subjects With BreAst Cancer Brain Metastases
Enrollment Status: Active_not_recruiting
Publish Date: July 10, 2026
Intervention Type: Radiation, Drug
Study Drugs: Olaparib, Durvalumab, Physicians Choice systemic chemotherapy
Study Phase: Phase 1/Phase 2
AVATAR Anesthesia Alternative in Pediatric Radiotherapy: A Multi-Center Study
AVATAR Anesthesia Alternative in Pediatric Radiotherapy: A Multi-Center Study
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2026
Intervention Type: Other, Device
Randomized Trial of Parotid Sparing Whole Brain Radiation
Randomized Trial of Parotid Sparing Whole Brain Radiation
Enrollment Status: Completed
Publish Date: April 25, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Phase II Randomized Study of Whole Brain Radiotherapy/Stereotactic Radiosurgery in Combination With Concurrent Lapatinib in Patients With Brain Metastasis From HER2-Positive Breast Cancer - A Collaborative Study of NRG Oncology and KROG
Enrollment Status: Completed
Publish Date: October 17, 2023
Intervention Type: Other, Radiation, Drug
Study Drug: Lapatinib Ditosylate
Study Phase: Phase 2
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the Oropharynx
Enrollment Status: Completed
Publish Date: May 31, 2023
Intervention Type: Other
Study Phase: Not Applicable
View 6 Less Clinical Trials

71 Total Publications

Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma.
Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma.
Journal: JAMA otolaryngology-- head & neck surgery
Published: April 23, 2026
Similar Doctors
Expertise in
27
conditions
Dr. David G. Kirsch
Radiation Oncology
Expertise in
27
conditions
Dr. David G. Kirsch
Radiation Oncology
Referral may be required

Private Diagnostic Clinic PLLC

2100 Erwin Rd, 
Durham, NC 
 (9.7 miles away)
919-684-8111
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Kirsch is a Radiation Oncologist practicing medicine in Durham, North Carolina. Dr. Kirsch is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Myxoid Liposarcoma, Undifferentiated Pleomorphic Sarcoma, and Rhabdomyosarcoma. Dr. Kirsch is currently accepting new patients.

Expertise in
8
conditions
Dr. Erik E. Sulman
Radiation Oncology
Expertise in
8
conditions
Dr. Erik E. Sulman
Radiation Oncology
Referral may be required

Duke University Health System Inc

20 Duke Medicine Cir, 
Durham, NC 
 (9.4 miles away)
919-668-5640
Languages Spoken:
English
See accepted insurances

Erik Sulman is a Radiation Oncologist practicing medicine in Durham, North Carolina. Dr. Sulman is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Gliomatosis Cerebri, and Gamma Knife Radiosurgery.

Expertise in
11
conditions
Dr. Zhongxing X. Liao
Radiation Oncology
Expertise in
11
conditions
Dr. Zhongxing X. Liao
Radiation Oncology
Referral may be required

UT MD Anderson Cancer Center

210 Ashville Ave # 408, 
Cary, NC 
 (19.6 miles away)
713-792-6161
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Zhongxing Liao is a Radiation Oncologist practicing medicine in Cary, North Carolina. Dr. Liao is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Esophageal Cancer, and Small Cell Lung Cancer (SCLC).

Frequently Asked Questions about Dr. Colette J. Shen

How do I make an appointment with Dr. Colette J. Shen?

You can book an appointment with Dr. Colette J. Shen by calling their office at 984-974-8415. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Colette J. Shen a top-rated expert for Oral Squamous Cell Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Colette J. Shen is classified as an Advanced expert for Oral Squamous Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Colette J. Shen specialize in?

While Dr. Colette J. Shen is a Radiation Oncology, they have specific expertise in Oral Squamous Cell Carcinoma, Throat Cancer, and Laryngeal Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Radiation Oncology.

Does Dr. Colette J. Shen participate in research or clinical trials?

Yes. Dr. Colette J. Shen has published 71 articles and abstracts on conditions like Oral Squamous Cell Carcinoma. You can view a list of Dr. Colette J. Shen's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Colette J. Shen accept my insurance?

Dr. Colette J. Shen accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 984-974-8415 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shen's expertise for a condition
ConditionClose
      View All 14 Advanced Conditions
      View All 56 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile